Latest Articles
Molecular Subtypes of Endometrial Cancer - OncLive
Molecular Subtypes of Endometrial Cancer OncLive
Published: Nov. 3, 2025, 1:36 p.m.
Frontline Considerations for Immunotherapy in Endometrial Cancer - OncLive
Frontline Considerations for Immunotherapy in Endometrial Cancer OncLive
Published: Nov. 3, 2025, 1:36 p.m.
Eisai Demonstrates Commitment to Advanced Endometrial Cancer Care at IGCS 2025 - Yahoo! Finance Canada
Eisai Demonstrates Commitment to Advanced Endometrial Cancer Care at IGCS 2025 Yahoo! Finance Canada
Published: Nov. 3, 2025, 1:08 p.m.
Eisai Demonstrates Commitment to Advanced Endometrial Cancer Care at IGCS 2025 - PR Newswire
Eisai Demonstrates Commitment to Advanced Endometrial Cancer Care at IGCS 2025 PR Newswire
Published: Nov. 3, 2025, 1:08 p.m.
Effects of miR-210-3p/SDF2 and miR-31-5p/FGF7 from hypoxic endometrial exosomes on UCB-MSC proliferation, migration, and differentiation - Stem Cell Research & Therapy
Effects of miR-210-3p/SDF2 and miR-31-5p/FGF7 from hypoxic endometrial exosomes on UCB-MSC proliferation, migration, and differentiation Stem Cell Research & Therapy
Published: Nov. 3, 2025, 10:18 a.m.
FAK-dependent activation of src family kinase member BLK contributed to endometrial fibrosis via endoplasmic reticulum stress - Cell & Bioscience
FAK-dependent activation of src family kinase member BLK contributed to endometrial fibrosis via endoplasmic reticulum stress Cell & Bioscience
Published: Oct. 31, 2025, 9:23 a.m.
Endometrial Cancer Treatment Market Forecast to grow USD 53.7 Billion by 2035 at a CAGR of 5.3 % | FMI Analysis - industrytoday.co.uk
Endometrial Cancer Treatment Market Forecast to grow USD 53.7 Billion by 2035 at a CAGR of 5.3 % | FMI Analysis industrytoday.co.uk
Published: Oct. 31, 2025, 8:31 a.m.
Endometrial Cancer in Young Women: Insights From a Tunisian Cohort - Cureus
Endometrial Cancer in Young Women: Insights From a Tunisian Cohort Cureus
Published: Oct. 31, 2025, 6:32 a.m.
Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment - MSN
Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment MSN
Published: Oct. 30, 2025, 10:54 a.m.
Iovance Biotherapeutics Advances in Endometrial Cancer Treatment with Lifileucel Study - MSN
Iovance Biotherapeutics Advances in Endometrial Cancer Treatment with Lifileucel Study MSN
Published: Oct. 30, 2025, 10:49 a.m.
Link copied to clipboard!